C-KIT Signaling in Cancer Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|17|2849-2880

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.17, 2014-05, pp. : 2849-2880

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Importance of c-Kit and PDGF Receptors as Potential Targets for Molecular Therapy in Breast Cancer

By  

Current Medicinal Chemistry, Vol. 14, Iss. 7, 2007-03 ,pp. : 735-743

Bentham Science Publishers

Access to resources Recommend Favorite

Biology of Protooncogene c-kit Receptor and Spermatogenesis

By  

Current Pharmacogenomics, Vol. 2, Iss. 1, 2004-03 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF Signaling in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2834-2842

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of c-kit Protein and Mutational Status of the c-kit Gene in Osteosarcoma and Their Clinicopathological Significance

By Wei H   Zhao MQ   Dong W   Yang Y   Li JS  

The Journal of International Medical Research, Vol. 36, Iss. 5, 2008-09 ,pp. : 1008-1014

Field House Publishing

Access to resources Recommend Favorite

CD95 Signaling in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2809-2818

Bentham Science Publishers

Access to resources Recommend Favorite